08 May 2025

Xbrane Biopharma releases Interim Report January-March 2025

05 May 2025

Announcement from the annual general meeting in Xbrane Biopharma AB

04 May 2025

Invitation to presentation of Xbrane Biopharma’s interim report January – March 2025 on May 8, 2025

14 Apr 2025

Announcement from extra general meeting in Xbrane Biopharma AB

02 Apr 2025

NOTICE OF ANNUAL GENERAL MEETING IN XBRANE BIOPHARMA AB

31 Mar 2025

XBRANE BIOPHARMA RELEASES ANNUAL AND SUSTAINABILITY REPORT FOR 2024

20 Mar 2025

Notice of Extra General Meeting in Xbrane Biopharma AB

20 Mar 2025

Xbrane has entered into an agreement to sell XB003 (Cimzia biosimilar candidate) and parts of its organization to Alvotech for a total consideration of SEK 275 million

20 Feb 2025

Xbrane Biopharma releases Year-end Report 2024